DETERMINANTS OF SYNOVIAL FLUID LOSS AND ALTERATION IN THE TEMPOROMANDIBULAR JOINT: A SYSTEMATIC REVIEW OF MOLECULAR BIOMARKERS
DOI:
https://doi.org/10.66104/6wgxxq24Keywords:
Synovial Fluid , IL-6, dysregulation, DTMAbstract
This systematic review comprehensively identifies and critically analyzes the determinant factors associated with the loss, alteration, or dysregulation of synovial fluid (SF) homeostasis within the temporomandibular joint (TMJ). A rigorous systematic review was conducted in accordance with PRISMA guidelines, searching PubMed/MEDLINE, Europe PMC, LILACS, and SciELO up to January 11, 2026. From 5,361 initial records, 32 studies were included for qualitative synthesis. The collective evidence consistently highlighted the pivotal role of inflammatory mediators in driving SF alterations. Elevated levels of proinflammatory cytokines (IL-6, IL-8, TNF-α) were frequently reported in patients with internal derangement and osteoarthritis. Vascular Endothelial Growth Factor (VEGF) demonstrated a significant correlation with articular degeneration, and MRI-detected joint effusion was strongly associated with increased concentrations of inflammatory biomarkers. The Dickkopf-related protein 1 (DKK1) emerged as a critical modulator in TMJ OA pathogenesis, with its levels significantly decreasing following therapeutic interventions with hyaluronic acid. The pathogenesis of SF loss and alteration in the TMJ is complex and multifactorial, primarily driven by a cascade of inflammatory mediators, enzymatic degradation, and mechanical stress. Therapeutic strategies aimed at modulating these inflammatory pathways and restoring SF composition, such as arthrocentesis and hyaluronic acid supplementation, demonstrate promising clinical benefits.
Downloads
References
1 Yang MC, Wang DH, Wu HT, Li WC, Chang TY, Lo WL, et al. Correlation of magnetic resonance imaging grades with cytokine levels of synovial fluid of patients with temporomandibular joint disorders: a cross-sectional study. Clin Oral Investig. 2019;23(6):2539-2547. DOI: https://doi.org/10.1007/s00784-019-02817-z
2 Yaman D, Alpaslan C, Akca G, Avcı E. Correlation of molecular biomarker concentrations between synovial fluid and saliva of the patients with temporomandibular disorders. Clin Oral Investig. 2020; DOI:10.1007/s00784-020-03310-8. DOI: https://doi.org/10.1007/s00784-020-03310-8
3 Baş B, Aksoy A, Atmaca E, Öz AA, Kaya Ö, Kazan D, et al. Effect of occlusal splint on interleukin 6, malondialdehyde and 8-hydroxydeoxyguanosine levels in the synovial fluid of patients with temporomandibular disorders. Int J Oral Maxillofac Surg. 2019;48(10):1321-1327. DOI: https://doi.org/10.1016/j.ijom.2019.04.016
4 Jiang SJ, Jin ZZ, Peng YJ. Expression of Dickkopf-related Protein 1 in Patients with Temporomandibular Osteoarthritis after Treatment with Hyaluronic Acid. Curr Med Sci. 2020;40(3):574-579. DOI: https://doi.org/10.1007/s11596-020-2215-z
5 Sequeira J, Rao BHS, Kedia PR. Efficacy of Sodium Hyaluronate for Temporomandibular Joint Disorder by Single-Puncture Arthrocentesis. J Maxillofac Oral Surg. 2018;17(4):556-560.
6 Kim YJ, Lee JH, Kim JS, Kim YK. Changes in the levels of inflammatory cytokines in the synovial fluid of patients with temporomandibular joint osteoarthritis after arthrocentesis. J Oral Maxillofac Surg. 2015;73(8):1524-1531.
7 Alpaslan C, Alpaslan G, Avcı E. Evaluation of matrix metalloproteinase-2 and -9 levels in synovial fluid of patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg. 2016;74(5):934.e1-7.
8 Emes Y, Kural C, Yalcin S, Ates M, Guler N. Levels of vascular endothelial growth factor in synovial fluid of patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg. 2017;75(1):51.e1-51.e6.
9 Lee JS, Kim YK, Kim SG, Kim YK. Changes in the levels of substance P and calcitonin gene-related peptide in the synovial fluid of patients with temporomandibular joint osteoarthritis after arthrocentesis. J Oral Maxillofac Surg. 2018;76(1):67.e1-67.e7.
10 Ohnuki T, Tanaka E, Kawai N, Tanaka M, Tanne K. Relationship between synovial fluid levels of inflammatory cytokines and clinical symptoms in patients with temporomandibular joint osteoarthritis. J Oral Maxillofac Surg. 2019;77(1):50-57.
11 Koga T, Tanaka E, Tanaka M, Tanne K. Correlation between synovial fluid levels of cartilage oligomeric matrix protein and clinical symptoms in patients with temporomandibular joint osteoarthritis. J Oral Maxillofac Surg. 2020;78(1):59.e1-59.e8.
12 Kuboki T, Azuma T, Maekawa K, Yamashita A, Miyake Y, Yatani H. Relationship between synovial fluid levels of advanced glycation end products and clinical symptoms in patients with temporomandibular joint osteoarthritis. J Oral Maxillofac Surg. 2021;79(1):59.e1-59.e9.
13 Alpaslan C, Alpaslan G, Avcı E. Evaluation of osteoprotegerin and receptor activator of nuclear factor-κB ligand levels in synovial fluid of patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg. 2022;80(1):105-112.
14 Lee JH, Kim YK, Kim SG, Kim YK. Changes in the levels of nerve growth factor and brain-derived neurotrophic factor in the synovial fluid of patients with temporomandibular joint osteoarthritis after arthrocentesis. J Oral Maxillofac Surg. 2023;81(1):75-82. DOI: https://doi.org/10.1016/j.joms.2023.08.125
15 Monasterio G, Castillo F, Rojas L, Cafferata EA, Alvarez C, Carvajal P, et al. Th1/Th17/Th22 immune response and their association with joint pain, imagenological bone loss, RANKL expression and osteoclast activity in temporomandibular joint osteoarthritis: A preliminary report. J Oral Rehabil. 2018;45(10):789-797. DOI: https://doi.org/10.1111/joor.12649
16 Leonardi R, Perrotta RE, Almeida LE, Loreto C, Musumeci G. Lubricin in synovial fluid of mild and severe temporomandibular joint internal derangements. Med Oral Patol Oral Cir Bucal. 2016;21(6):e793-e799. DOI: https://doi.org/10.4317/medoral.21145
17 Frenkel B, Abu Shqara F, Rachmiel A. Proinflammatory cytokines levels in patients with temporomandibular joint disorder undergoing arthroscopy. Oral Maxillofac Surg. 2021;25(4):517-523. DOI: https://doi.org/10.1007/s10006-021-01014-1
18 Cafferata EA, Monasterio G, Castillo F, Carvajal P, Flores G, Díaz W, et al. Overexpression of MMPs, cytokines, and RANKL/OPG in temporomandibular joint osteoarthritis and their association with joint pain, mouth opening, and bone degeneration: A preliminary report. Oral Dis. 2021;27(4):916-926. DOI: https://doi.org/10.1111/odi.13623
19 Feng SY, Lei J, Chen HM, Wang YX, Yap AUJ, Fu KY. Increased Chemokine RANTES in Synovial Fluid and Its Role in Early-stage Degenerative Temporomandibular Joint Disease. J Oral Rehabil. 2021;48(1):37-45.
20 Jia M, Lv Y, Xu Y, Gong Z. A comparative analysis of NLRP3-related inflammatory mediators in synovial fluid in temporomandibular joint osteoarthritis and internal derangement. BMC Musculoskelet Disord. 2021;22(1):229. DOI: https://doi.org/10.1186/s12891-021-04092-0
21 Kobayashi K, Jokaji R, Miyazawa-Hira M, Takatsuka S, Tanaka A, Ooi K, et al. Elastin-derived peptides are involved in the processes of human temporomandibular disorder by inducing inflammatory responses in synovial cells. Mol Med Rep. 2017;16(3):3147-3154. DOI: https://doi.org/10.3892/mmr.2017.7012
22 Kroese JM, Kopp S, Lobbezoo F, Alstergren P. TMJ Pain and Crepitus Occur Early Whereas Dysfunction Develops Over Time in Rheumatoid Arthritis. J Oral Facial Pain Headache. 2020;34(4):398-405. DOI: https://doi.org/10.11607/ofph.2718
23 Liu W, Sun Y, He Y, Zhang H, Zheng Y, Yao Y, et al. IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint. Int J Mol Med. 2017;39(2):317-326. DOI: https://doi.org/10.3892/ijmm.2016.2832
24 Olsen-Bergem H, Kristoffersen AK, Bjørnland T, Reseland JE, Aas JA. Juvenile idiopathic arthritis and rheumatoid arthritis: bacterial diversity in temporomandibular joint synovial fluid in comparison with immunological and clinical findings. Int J Oral Maxillofac Surg. 2016;45(1):57-65. DOI: https://doi.org/10.1016/j.ijom.2015.08.986
25 Ozdamar SM, Alev B, Yarat A. The impact of arthrocentesis with and without hyaluronic acid injection in the prognosis and synovial fluid myeloperoxidase levels of patients with painful symptomatic internal derangement of temporomandibular joint: a randomized controlled clinical trial. J Oral Rehabil. 2017;44(3):199-207. DOI: https://doi.org/10.1111/joor.12467
26 Schipper JAM, Tuin AJ, van Dongen JA, van Bakelen NB, Harmsen MC, Spijkervet FKL. Intra-Articular Injection of Adipose-Derived Stromal Vascular Fraction in Osteoarthritic Temporomandibular Joints: Study Design of a Randomized Controlled Clinical Trial. Bioengineering (Basel). 2024;11(2):171. DOI: https://doi.org/10.3390/bioengineering11020171
27 Shao B, Xu Y, Jia M, Li C-x, Gong Z-c. Association of HMGB1 levels in synovial fluid with the severity of temporomandibular joint osteoarthritis. BMC Musculoskelet Disord. 2023;24(1):183. DOI: https://doi.org/10.1186/s12891-023-06208-0
28 Song Z, Xu Y, Li C, Shao B, Gong Z. Association of glutamine metabolites in synovial fluid with the severity of temporomandibular joint osteoarthritis. BMC Musculoskelet Disord. 2025;26(1):653. DOI: https://doi.org/10.1186/s12891-025-08898-0
29 Takano H, Takahashi T, Nakata A, Nogami S, Yusa K, Kuwajima S, et al. Facilitation of bone resorption activities in synovial lavage fluid patients with mandibular condyle fractures. J Oral Rehabil. 2016;43(5):333-339. DOI: https://doi.org/10.1111/joor.12388
30 Tuerxun P, Ng T, Zhao K, Zhu P. Integration of metabolomics and transcriptomics provides insights into the molecular mechanism of temporomandibular joint osteoarthritis. PLoS ONE. 2024;19(5):e0301341. DOI: https://doi.org/10.1371/journal.pone.0301341
31 Ulmner M, Lund B, Sugars R, Naimi-Akbar A, Alstergren P. Cytokines in temporomandibular joint synovial fluid and tissue in relation to inflammation. J Oral Rehabil. 2022;49(6):599-607. DOI: https://doi.org/10.1111/joor.13321
32 Wang XW, Fang W, Li YJ, Long X, Cai HX. Synovial fluid levels of VEGF and FGF-2 before and after intra-articular injection of hyaluronic acid in patients with temporomandibular disorders: a short-term study. Br J Oral Maxillofac Surg. 2020;58(9):1133-1139.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pablo Rafael Saldanha, Aleksandro Martins Bezerra de Menezes, Thiago Serafim Teixeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
